Sarcopenia is the progressive and generalised loss of skeletal muscle mass and strength associated with ageing, leading to adverse effects such as disability, diminished quality of life, morbidity and mortality1. Whilst, geriatric syndrome, is multifaceted, serious health conditions that does not fit into discrete disease categories such as immobility, incompetence and incontinence2, but is highly prevalent and associated with several comorbidities and poor outcomes3.
Sarcopenia is increasingly prevalent in older populations worldwide, with more than 50% of the population over the age of 80 affected4. Although the aetiology of sarcopenia remains unclear, it is suggested to be associated with multiple risk factors and complex pathophysiology,
Sarcopenia is increasingly prevalent in older populations worldwide, with more than 50% of the population over the age of 80 affected4. Although the aetiology of sarcopenia remains unclear, it is suggested to be associated with multiple risk factors and complex pathophysiology,